Karl-Friedrich Kowalewski

The TALAPRO-3 study met its primary endpoint. Overall survival data are still immature and not yet statistically significant. We will have to wait and see how much benefit is observed in the HRR and non-HRR subgroups, but this is great news!!

🤖 How ready is your urology department for AI? We’re mapping the AI maturity of urologic centers worldwide — and we need your input. 👨‍⚕️ Open to all urologists ⏱ Takes only 8 minutes Help shape the future of AI in urology 👇 🔗 surveymonkey.com/r/RR93FTP @EAUYAUrology @Uroweb

Scientists at the DKFZ and @uniklinik_hd are presenting a method known as “xeno-learning" that enables artificial intelligence (AI) to learn how to transfer medical image data from animals to humans. @lena_maierhein @natBME t1p.de/8jzg3

🚨 Our 2-year results from the randomized ROBOCOP II trial are out. RAPN vs OPN for localized RCC: 📖sciencedirect.com/science/articl… @KFKowalewski @HaneyCaelan @MaximilianKriegmair @UMM_Urology

🚀 New in Nature Biomedical Engineering: "Xeno-learning: transferring knowledge across species for hyperspectral imaging" 📄doi.org/10.1038/s41551… Jan Sellner, @AlexanderStuFi, @lena_maierhein, @doctor_felix, @KFKowalewski, @DKFZ

MUST READ for urologist and radonc! Real world data on late GU toxicity after radiotherapy for prostate cancer Short term is underestimation of the real burden for the patient. Important when counselling patients for decision making. @aleantonellibs1 @RicBertolo

🚨23 years of PSA screening in @NEJM 🚨 👉ERSPC RCT of >162k patients 📅Median 23 year f/u PSA screening lead to... 📉 #prostatecancer mortality by 13% ✅1 death prevented for every 456 men invited for screening or 12 diagnosed w/ PCa 📉Risk of advanced PCa by 34% ⭐️Benefit continues to rise over time as harm-benefit ratio improves 🔗shorturl.at/ajgNN @PCF_Science @PCFnews @urotoday @UrologyTimes @renalandurology @UroOnc

🚨Just in @NatureMedicine 👉 results from the Ph 3 AMPLITUDE trial: adding niraparib to abiraterone ⬆️outcomes in HRR-altered mHSPC #prostatecancer 👉 RPFS ⬆️: BRCA 1/2 HR 0.52, P < 0.0001; ITT HR 0.63, P =0.0001 Open link👉 bit.ly/47lt5Oj @PCFnews @OncoAlert @urotoday

Excited to share our latest publication in @EurUrolOpen : Hyperspectral Imaging can accurately visualize renal malperfusion induced by high intrarenal pressure 🔬doi.org/10.1016/j.euro… @LuisaHartung @AlexanderStuFi @HaneyCaelan @KFKowalewski @lena_maierhein @DKFZ @UMM_Urology

[via @uroai_news] Artificial Intelligence Generates Multilingual Cancer Patient Materials with Superior Readability and Equivalent Accuracy, Clarity, and Completeness to Expert-Written Texts uroai.org/blogs/blogdeta…

🚨 KN-905/EV-303: pembrolizumab + enfortumab vedotin before & after surgery in cisplatin-ineligible muscle-invasive bladder cancer 🩺 led to: ✅ Longer event-free survival ✅ Longer overall survival ✅ Higher complete response rates #Oncology @OncoAlert merck.com/news/keytruda-…

Perioperative EVP shows ⬆️ EFS,OS & pCR vs cystectomy alone in high risk cisplatin ineligible MIBC (KN901). Highly active systemic vs surgery will rescue many patients with aggressive micrometastatic disease. CRs for EVP=30% in M1 but should be ⬆️ in MIBC biospace.com/press-releases…

It was a great pleasure to welcome @SigridCarlsson to @UMM_Urology yesterday. We look forward to improve screening and early detection in prostate cancer for our patients 👏 @DKFZ @unimedizinma @KFKowalewski @HaneyCaelan

Gem/cis/durvalumab is approved in the EU for muscle invasive bladder cancer (NIAGARA study). It’s the only immune therapy study in the adjuvant or neoadjuvant setting with significant OS. ⬆️ pCR and EFS support this appr @OncoAlert @Annals_Oncology astrazeneca.com/media-centre/p…

Check out our newest publication led by @HaneyCaelan and @KFKowalewski on ICG-guided resection of ureters for the prevention of ureterointestinal stenoses @BJUIjournal --> doi.org/10.1111/bju.16…

What is EVIglance?

Honored to be part of the plenary session on optimizing the patient journey at #EAU25 with @spsutkaMD, chaired by the brilliant @jamescatto1 and @KariTikkinen!

Prehabilitation: diet, sleep, and psychological preparation. Presentation by @KFKowalewski @UMM_Urology. #EAU25 written coverage by @zklaassen_md @GACancerCenter > bit.ly/4bWVgEZ @Uroweb

🚀 Meet the YAU UroTech Team – Innovation and digital health to bring back the joy of practicing medicine! 🔹 Digital Health Focus – Leveraging cutting-edge tech to improve patient care 💼 Reduce Workload – Smart automation to lighten the load on healthcare providers ⚙️ Streamline Workflow – Keeping things smooth and efficient 📈 Enhance Performance – Boosting outcomes with AI-driven insights ❤️ Rediscover the Joy – Less stress, more focus on patient care #DigitalHealth #MedTech #Innovation #Healthcare @EAUYAUrology @Uroweb #EAU25

⚠️For the 1st time in almost 50 years something shows superiority to #BCG alone in HR-NMIBC 🔗 tinyurl.com/5n74kfv8 🍾Today makes history! 🧐Looking forward to the data in detail 🤩Happy to be part of this with my team @Urologia12 @cgdelcanizo @MarioHArroyo @RodriguezFaba @malvarezmaestro @BerUrologia @joanfundi @DominguezEscrig @cdanicas @GUOaeu @InfoAeu @GuardConsortium @dralvaropinto @docjavip @g_develasco @drenriquegrande @ROC_Urologia @MariaJRibal @A_Carrion_Puig @dr_flozano @josedsh @UroDocAsh @siadaneshmand @PGrivasMDPhD @nachoduranm @AlisonBirtle @pfizer @diariomedico @AndreaNecchi @BenjaminPradere @MRoupret @DrShariat @paolo_gontero @jteoh_hk @so_uro @tompowles1 @elenasefer @tonivilaseca @AntonioAlcarazA @jgarciadonas @jesusmfergomez @maxicastrovigo @IBCG_BladderCA